IE
WGS icon

Israel Englander’s GeneDx Holdings WGS Stock Holding History

Israel Englander’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-65,000
Closed -$8.45M – 6459
2025
Q4 		$8.45M Buy
+65,000
New +$8.92M ﹤0.01% 2445

Other funds holding WGS

CM
Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Israel Englander's WGS Position: Q2 2026 in Review

Israel Englander increased its GeneDx Holdings (WGS) stake by 3.8% in Q2 2026, buying an estimated $322K and bringing the position to 155,575 shares worth $10.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2222.

Israel Englander first reported a position in WGS in Q4 2020 and has held it in 16 quarters since. The position peaked at $24.4M in Q3 2024. 222 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

  • Israel Englander held 155,575 shares of GeneDx Holdings worth $10.7M as of Q2 2026.
  • Israel Englander bought 5,669 GeneDx Holdings shares in Q2 2026, an estimated $322K.
  • GeneDx Holdings made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #2222 holding.
  • Israel Englander first reported a position in GeneDx Holdings in Q4 2020 and has held it in 16 quarters since.
  • Israel Englander's GeneDx Holdings position peaked at $24.4M in Q3 2024.
  • 222 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.